MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 8, 2014, Pages 480-488

  Beets Tan, Regina G H ^a   Beets, Geerard L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE; GADOTERIC ACID;

ADJUVANT CHEMORADIOTHERAPY; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS TECHNOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 84905680049     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.41     Document Type: Review

References (75)

1. van de Velde, C. J. et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur. J. Cancer 50, 1.e1-1.e34 (2014).
2. Engelen, S. M. et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur. J. Cancer 49, 2311-2320 (2013).
3. Maas, M. et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 11, 835-844 (2010).
4. Maas, M. et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J. Clin. Oncol. 29, 4633-4640 (2011).
5. Habr-Gama, A., Perez, R. O., Sao Juliao, G. P., Proscurshim, I. & Gama-Rodrigues, J. Nonoperative approaches to rectal cancer: a critical evaluation. Semin. Radiat. Oncol. 21, 234-239 (2011).
6. Habr-Gama, A. et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis. Colon Rectum 53, 1692-1698 (2010).
7. Perez, R. O. et al. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Colorectal Dis. 14, 714-720 (2012).
8. Lambin, P. et al. Predicting outcomes in radiation oncology- multifactorial decision support systems. Nat. Rev. Clin. Oncol. 10, 27-40 (2013).
9. van Stiphout, R. G. et al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother. Oncol. 98, 126-133 (2011).
10. MacGregor, T. P., Maughan, T. S. & Sharma, R. A. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now. J. Clin. Pathol. 65, 867-871 (2012).
11. Sloothaak, D. A. et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br. J. Surg. 100, 933-939 (2013).
12. Vliegen, R. F. et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 246, 454-462 (2008).
13. Kulkarni, T. et al. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status. Colorectal Dis. 10, 479-489 (2008).
14. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333, 779 (2006).
15. Beets-Tan, R. G. & Beets, G. L. Local staging of rectal cancer: review of imaging. J. Magn. Reson. Imaging 33, 1012-1019 (2011).
16. Vanagunas, A., Lin, D. E. & Stryker, S. J. Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am. J. Gastroenterol. 99, 109-112 (2004).
17. Napoleon, B. et al. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br. J. Surg. 78, 785-788 (1991).
18. Radovanovic, Z., Breberina, M., Petrovic, T., Golubovic, A. & Radovanovic, D. Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation. Surg. Endosc. 22, 2412-2415 (2008).
19. Huh, J. W., Park, Y. A., Jung, E. J., Lee, K. Y. & Sohn, S. K. Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation. J. Am. Coll. Surg. 207, 7-12 (2008).
20. Pastor, C. et al. Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: can we trust the findings? Dis. Colon Rectum 54, 1141-1146 (2011).
21. van der Paardt, M. P., Zagers, M. B., Beets-Tan, R. G., Stoker, J. & Bipat, S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 269, 101-112 (2013).
22. Dresen, R. C. et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252, 71-80 (2009).
23. Barbaro, B. et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250, 730-739 (2009).
24. Curvo-Semedo, L. et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260, 734-743 (2011).
25. Ha, H. I., Kim, A. Y., Yu, C. S., Park, S. H. & Ha, H. K. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur. Radiol. 23, 3345-3353 (2013).
26. Padhani, A. R. & Miles, K. A. Multiparametric imaging of tumor response to therapy. Radiology 256, 348-364 (2010).
27. Figueiras, R. G. et al. The role of functional imaging in colorectal cancer. AJR Am. J. Roentgenol. 195, 54-66 (2010).
28. Li, S. P. & Padhani, A. R. Tumor response assessments with diffusion and perfusion MRI. J. Magn. Reson. Imaging 35, 745-763 (2012).
29. Kuhl, C. K. et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211, 101-110 (1999).
30. Leach, M. O. et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br. J. Cancer 92, 1599-1610 (2005).
31. Tofts, P. S. et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223-232 (1999).
32. Oberholzer, K. et al. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J. Magn. Reson. Imaging 38, 119-126 (2013).
33. Gollub, M. J. et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur. Radiol. 22, 821-831 (2012).
34. Lim, J. S. et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur. Radiol. 22, 1693-1700 (2012).
35. Lambregts, D. M. et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann. Surg. Oncol. 18, 2224-2231 (2011).
36. Sun, Y. S. et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254, 170-178 (2010).
37. Ippolito, D. et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom. Imaging 37, 1032-1040 (2012).
38. Jung, S. H. et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J. Magn. Reson. Imaging 35, 110-116 (2012).
39. Lambrecht, M. et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 82, 863-870 (2012).
40. Monguzzi, L. et al. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur. J. Radiol. 82, 234-240 (2013).
41. Intven, M., Reerink, O. & Philippens, M. E. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther. Onkol. 189, 117-122 (2013).
42. Kim, S. H. et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 253, 116-125 (2009).
43. Kim, S. H., Lee, J. Y., Lee, J. M., Han, J. K. & Choi, B. I. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur. Radiol. 21, 987-995 (2011).
44. Song, I. et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br. J. Radiol. 85, 577-586 (2012).
45. Yu, S. K., Tait, D., Chau, I. & Brown, G. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy-implications for induction chemotherapy? Int. J. Radiat. Oncol. Biol. Phys. 87, 505-511 (2013).
46. Chang, G. J. et al. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis. Colon Rectum 55, 371-377 (2012).
47. Oberholzer, K. et al. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int. J. Radiat. Oncol. Biol. Phys. 82, 842-848 (2012).
48. Hermans, R. et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 1351-1356 (2003).
49. Zahra, M. A., Hollingsworth, K. G., Sala, E., Lomas, D. J. & Tan, L. T. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 8, 63-74 (2007).
50. George, M. L. et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br. J. Surg. 88, 1628-1636 (2001).
51. Devries, A. F. et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 61, 2513-2516 (2001).
52. de Vries, A. et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 217, 385-391 (2000).
53. Kremser, C., Trieb, T., Rudisch, A., Judmaier, W. & de Vries, A. Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J. Magn. Reson. Imaging 26, 662-671 (2007).
54. DeVries, A. F. et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56, 958-965 (2003).
55. Kim, Y. C. et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J. Magn. Reson. Imaging 34, 570-576 (2011).
56. Barbaro, B. et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 83, 594-599 (2012).
57. Lambrecht, M. et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 49, 956-963 (2010).
58. Beets-Tan, R. G. et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 23, 2522-2531 (2013).
59. Kim, M. J. et al. Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy. Magn. Reson. Imaging 30, 848-853 (2012).
60. Kyriazi, S. et al. Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging-value of histogram analysis of apparent diffusion coefficients. Radiology 261, 182-192 (2011).
61. Wilmes, L. J. et al. High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response. Acad. Radiol. 20, 581-589 (2013).
62. Kluza, E. et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer. Eur. Radiol. 23, 253-261 (2013).
63. Carbone, S. F. et al. Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report. Radiol. Med. 117, 1112-1124 (2012).
64. Castellano, G., Bonilha, L., Li, L. M. & Cendes, F. Texture analysis of medical images. Clin. Radiol. 59, 1061-1069 (2004).
65. Goh, V. et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261, 165-171 (2011).
66. Ng, F., Ganeshan, B., Kozarski, R., Miles, K. A. & Goh, V. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266, 177-184 (2013).
67. Miles, K. A., Ganeshan, B., Griffiths, M. R., Young, R. C. & Chatwin, C. R. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 250, 444-452 (2009).
68. Freeborough, P. A. & Fox, N. C. MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease. IEEE Trans. Med. Imaging 17, 475-479 (1998).
69. Lerski, R. A. et al. MR image texture analysis-an approach to tissue characterization. Magn. Reson. Imaging 11, 873-887 (1993).
70. Sinha, S. et al. Multifeature analysis of Gd-enhanced MR images of breast lesions. J. Magn. Reson. Imaging 7, 1016-1026 (1997).
71. Chen, W., Giger, M. L., Li, H., Bick, U. & Newstead, G. M. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn. Reson. Med. 58, 562-571 (2007).
72. Kjaer, L., Ring, P., Thomsen, C. & Henriksen, O. Texture analysis in quantitative MR imaging. Tissue characterisation of normal brain and intracranial tumours at 1.5 T. Acta Radiol. 36, 127-135 (1995).
73. Gibbs, P. & Turnbull, L. W. Textural analysis of contrast-enhanced MR images of the breast. Magn. Reson. Med. 50, 92-98 (2003).
74. Ahmed, A., Gibbs, P., Pickles, M. & Turnbull, L. Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J. Magn. Reson. Imaging 38, 89-101 (2013).
75. Ganeshan, B. et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266, 326-336 (2013).